Korro Bio Statistics
Want to see KRRO full AI Analyst Report?
Korro Bio (KRRO) Stock Statistics & Valuation Metrics
Total Valuation
Korro Bio has a market cap or net worth of $197.79M. The enterprise value is $113.59M.
- Market Cap
- $197.79M
- Enterprise Value
- $113.59M
Share Statistics
Korro Bio has 13,725,646 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 13,725,646
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Korro Bio’s return on equity (ROE) is -2.28 and return on invested capital (ROIC) is -83.79%.
- Return on Equity (ROE)
- -2.28
- Return on Assets (ROA)
- -1.03
- Return on Invested Capital (ROIC)
- -83.79%
- Return on Capital Employed (ROCE)
- -0.86
- Revenue Per Employee
- 110.21K
- Profits Per Employee
- -2.02M
- Employee Count
- 58
- Asset Turnover
- 0.06
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Korro Bio is -1.56. Korro Bio’s PEG ratio is 0.15.
- PE Ratio
- -1.56
- PS Ratio
- 158.07
- PB Ratio
- 2.86
- Price to FCF
- -3.20
- Price to Operating Cash Flow
- -3.97
- PEG Ratio
- 0.15
Income Statement
In the last 12 months, Korro Bio had revenue of 6.39M and earned -117.26M in profits. Earnings per share was -12.48.
- Revenue
- 6.39M
- Gross Profit
- 2.11M
- Operating Income
- -87.34M
- Pretax Income
- -116.62M
- Net Income
- -117.26M
- EBITDA
- -83.06M
- Earnings Per Share (EPS)
- -12.48
Cash Flow
In the last 12 months, operating cash flow was -63.70M and capital expenditures -169,000, giving a free cash flow of -63.87M billion.
- Operating Cash Flow
- -63.70M
- Free Cash Flow
- -63.87M
- Free Cash Flow per Share
- -3.57
Dividends & Yields
Korro Bio pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -31.01%
- Earnings Yield
- -41.60%
Stock Price Statistics
- Beta
- 2.44
- 52-Week Price Change
- -54.46%
- 50-Day Moving Average
- 11.72
- 200-Day Moving Average
- 12.15
- Relative Strength Index (RSI)
- 57.03
- Average Volume (3m)
- 181.68K
Important Dates
Korro Bio upcoming earnings date is Mar 30, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Mar 30, 2027
- Ex-Dividend Date
- ―
Financial Position
Korro Bio as a current ratio of 6.90, with Debt / Equity ratio of 84.54%
- Current Ratio
- 6.90
- Quick Ratio
- 6.90
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.26
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Korro Bio has paid 637.00K in taxes.
- Income Tax
- 637.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
Korro Bio EV to EBITDA ratio is -2.83, with an EV/FCF ratio of -3.24.
- EV to Sales
- 160.42
- EV to EBITDA
- -2.83
- EV to Free Cash Flow
- -3.24
- EV to Operating Cash Flow
- -3.25
Balance Sheet
Korro Bio has $104.99M in cash and marketable securities with $41.52M in debt, giving a net cash position of $63.47M billion.
- Cash & Marketable Securities
- $104.99M
- Total Debt
- $41.52M
- Net Cash
- $63.47M
- Net Cash Per Share
- $4.62
- Tangible Book Value Per Share
- $4.95
Margins
Gross margin is 49.77%, with operating margin of -5796.05%, and net profit margin of -8214.47%.
- Gross Margin
- 49.77%
- Operating Margin
- -5796.05%
- Pretax Margin
- -8129.41%
- Net Profit Margin
- -8214.47%
- EBITDA Margin
- -5660.60%
- EBIT Margin
- -5796.05%
Analyst Forecast
The average price target for Korro Bio is $19.83, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $19.83
- Price Target Upside
- 38.60% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 6
- Revenue Growth Forecast
- -82.47%
- EPS Growth Forecast
- 3.73%
Scores
- Smart Score
- 7
- AI Score
- 56
